Stay updated on Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial

Sign up to get notified when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Updates the ClinicalTrials.gov page footer from **Revision: v3.5.2** to **Revision: v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-24T05:58:52.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:39:25.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    - Removed the topic 'Non-alcoholic fatty liver disease' and the related topic 'MedlinePlus Genetics' from the page.
    Difference
    0.1%
    Check dated 2026-04-02T15:37:45.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 in the page header.
    Difference
    0.0%
    Check dated 2026-03-19T05:37:51.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T00:30:38.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Added Related topics entries for Non-alcoholic fatty liver disease and MedlinePlus Genetics on the study page.
    Difference
    0.1%
    Check dated 2026-02-25T18:32:52.000Z thumbnail image

Stay in the know with updates to Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.